Clinical Trial Detail

NCT ID NCT02042430
Title INCB024360 Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

ovarian carcinoma

peritoneum cancer

fallopian tube carcinoma

Therapies

Epacadostat

Age Groups: adult

No variant requirements are available.